Vertex Pharmaceuticals Incorpor vs Pfizer, Inc. — Stock Comparison
Q·Score Breakdown
8.4
Buy
Overall
6.5
Hold
Quality
Health
Growth
Valuation
Sentiment
VRTX
High-quality business with 23% return on equity and 33% profit margins.
PFE
Strong profitability with 12% net profit margins.
⚠ analyst sentiment is cautious.
Analyst Consensus
BUY
Target $548.39 (+28.1%)
28 analysts
HOLD
Target $29.00 (+8.7%)
27 analysts
Fundamentals
VRTX
PFE
27.9×
Trailing P/E
19.6×
19.7×
Forward P/E
9.5×
32.9%
Profit Margin
12.4%
53.7%
Gross Margin
75.8%
22.5%
ROE
8.9%
9.5%
Revenue Growth
-1.2%
32.9%
Earnings Growth
—
0.37
Beta
0.39
—
Price / Book
—
$108.9B
Market Cap
$151.8B
$363 – $509
52-Week Range
$22 – $29
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load.